Superdisintegrants Market worth $536.5 million by 2023

1
MarketsandMarkets Presents
Superdisintegrants Market 
www.marketsandmarkets.com
2
Factors contributing to the growth of this market
include the increasing adoption of orally
disintegrating tablets, growing generics market,
and the emergence of new superdisintegrants for
the pharmaceutical industry. The shifting focus
of pharmaceutical manufacturing to emerging
markets and the growth of the overall
pharmaceutical sector in these markets present
significant opportunities for the
superdisintegrants market growth. Browse 124
market data Tables and 37 Figures spread
through 182 Pages and in-depth TOC
on "Superdisintegrants Market https//www.markets
andmarkets.com/Market-Reports/superdisintegrants-m
arket-198068672.htmlEarly buyers will receive
10 customization on reports. The
superdisintegrants market is expected to reach
USD 536.5 million by 2023 from an estimated USD
366.4 million in 2018, at a CAGR of 7.9. 
Superdisintegrants Market
3
The report analyzes the global superdisintegrants
market by type, formulation, therapeutic area,
and region. By type, the synthetic
superdisintegrants segment accounted for the
largest share of the market in 2017. The large
share of this segment can be attributed to the
extensive consumption of these superdisintegrants
in various pharmaceutical drug formulations due
to the advantages offered such as effectiveness
at lower concentrations as compared to starch and
a lesser effect on the compressibility and
flowability of the dosage form. Download FREE
Brochure _at_. https//www.marketsandmarkets.com/pdfd
ownload.asp?id198068672 Based on formulation,
the tablets segment accounted for the larger
share of the global superdisintegrants market in
2017. The large share of this segment can be
attributed to tablets being the most widely used
dosage forms due to the benefits offered such as
stability, low manufacturing cost (as compared to
other dosage forms), easy product identification,
and compactness, along with the increasing focus
on orally disintegrating tablets and
fast-dissolving tablets.
http//www.marketsandmarkets.com/Market-Reports/as
ian-home-health-care-market-227642968.html
Superdisintegrants Market
4

Geographically, the global superdisintegrants
market is segmented into North America, Europe,
Asia Pacific, Latin America, and the Middle East
Africa. In 2017, Europe accounted for the
largest share of the superdisintegrants market,
followed by North America and Asia Pacific. The
dominance of the European region can be
attributed to the presence of a number of
pharmaceutical giants with large production
capacities leading to extensive consumption of
excipients. The growing emphasis on superior
pharmaceutical products and generics is also
expected to aid the market growth in the region.
Superdisintegrants Market
5
Based on therapeutic area, the neurological
diseases segment is expected to register the
highest CAGR during the forecast period. This can
be attributed to the increasing incidences of
neurological disorders at the global level along
with the growing demand for effective
therapies. Speak To Analyst _at_ https//www.markets
andmarkets.com/speaktoanalyst.asp?id198068672 Sa
fety and quality concerns are expected to
challenge the growth of the superdisintegrants
market to a certain extent during the forecast
period. The prominent players in the global
superdisintegrants market are Ashland Inc. (US),
BASF SE (Germany), DowDuPont (US), JRS Pharma
(Germany), DFE Pharma (Germany), Roquette
(France), Asahi Kasei Corporation (Japan), Merck
KGaA (Germany), Corel Pharma Chem (India), and
Avantor Performance Materials, LLC (US).
Superdisintegrants Market
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 7500 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions. Our 850 fulltime analyst and
SMEs at MarketsandMarkets are tracking global
high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.  
Superdisintegrants Market
7
Contact Us
ContactMr. Shelly SinghMarketsandMarkets
INC. 630 Dundee Road Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 sales_at_marketsandmarke
ts.com https//www.marketsandmarkets.com/ResearchI
nsight/healthcare-chatbots-market.asp